Test Overview
Test Methodology

LC-MS/MS

Test Usage

Paliperidone (9-hydroxyrisperidone) is the active ingredient in Invega extended-release tablets. Paliperidone is also the major active metabolite of Risperidone. Steady-state concentrations are typically attained within 4 to 5 days of dosing. Following daily administration of 12 mg extended release formulation, paliperidone steady state plasma concentrations ranged from 30 to 40 ng/mL.

Reference Range *

Reporting limit determined each analysis

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Sunday
Analytic Time

8 - 12 days

Soft Order Code
FPALI
MiChart Code
FPALI
Synonyms
    Laboratory
    Sendout
    Reference Laboratory
    Mayo FPALI (NMS Labs)
    Section
    Special Testing
    Specimen Requirements
    Collection

    Red top only, no SST

    Collection Instructions

    Collect specimen in a red top tube (NO SST). Spin and aliquot into a plastic, screw capped tube. Send to Specimen Processing refrigerated

    Special Handling

    Specimen cannot be shared with other testing once at Mayo. (no add-ons)

    Normal Volume
    1 mL serum
    Minimum Volume
    0.5 mL serum
    Storage Temperature
    Ambient is also acceptable
    Rejection Criteria
    Specimen collected in anything but a red top tube
    Additional Information

    Test sent to Mayo Clinic Labs; performed by NMS labs

    Billing
    CPT Code
    80342
    Fee Code
    AA588
    NY State Approved
    No